Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg Hypertension and Diabetes Project


    loading  Checking for direct PDF access through Ovid

Abstract

ObjectiveTo study the association between polymorphisms in the angiotensin converting enzyme (ACE) gene and angiotensinogen (AGT) gene and hypertension and/or type 2 diabetes in a community population.Patients and methodsThe insertion (I)/deletion (D) polymorphism of the ACE gene and the M235T polymorphism of the AGT gene were genotyped in 773 nondiabetic individuals with hypertension, 193 normotensive patients with type 2 diabetes, 243 patients with type 2 diabetes and hypertension, and in 820 normotensive control individuals identified in a community-based study.ResultsThe DD genotype was associated with hypertension in individuals less than 70 years [odds ratio (OR) = 1.54, confidence interval (CI) = 1.09–2.18] and remained so when patients with type 2 diabetes were excluded from the analysis (OR = 1.45, Cl = 1.01–2.09). The strongest association was with the combination of type 2 diabetes and hypertension (OR = 2.19, Cl = 1.09–4.38). There was no association with type 2 diabetes without hypertension. No association was observed between the M235T variant or the 3′-microsatellite polymorphism of the AGT gene and hypertension.ConclusionThe D-allele of the ACE gene ID polymorphism increases susceptibility to hypertension, particularly when associated with type 2 diabetes. No association was observed between the M235T variant or 3′-microsatellite polymorphism of the AGT gene and hypertension.

    loading  Loading Related Articles